![Fang Xiang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fang Xiang
Director/Board Member at Hrain Biotechnology Co., Ltd.
Profile
Fang Xiang is currently a Member-Supervisory Board & Medical Director at Hrain Biotechnology Co., Ltd.
His education includes a graduate degree from Wuhan University in 2004.
Fang Xiang active positions
Companies | Position | Start |
---|---|---|
Hrain Biotechnology Co., Ltd.
![]() Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Director/Board Member | 18/06/2021 |
Training of Fang Xiang
Wuhan University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Hrain Biotechnology Co., Ltd.
![]() Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Fang Xiang